Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 1;34(3):226-232.
doi: 10.1097/ACO.0000000000000996.

Peripartum management for women with opioid dependence

Jarna R Shah  1 , Abigail Ramseyer  2 , Jessica Coker  3
Affiliations
Review

Peripartum management for women with opioid dependence

Jarna R Shah et al. Curr Opin Anaesthesiol. .

Abstract

Purpose of review: Opioid use disorder (OUD) in pregnancy has more than quadrupled in prevalence over the past two decades and continues to increase steadily every year. With no defined standard of care for the management of pain during the peripartum period, variability in treatment plans potentially leaves room for interrupted patient care, decreased patient satisfaction, and poorer outcomes. The impact of OUD and its management during the peripartum period has become more widely discussed over the past several years and is the focus of this review.

Recent findings: Current recommendations including developing a detailed institutional plan for the management of pain for women with OUD during the intrapartum and postpartum periods. There is tremendous value in exploring partnerships with other specialties, including addiction medicine, and behavioral health and obstetrics in development of policies and procedures. Consistency within institutions is critical to improve patient outcomes.

Summary: This review will address both pain management recommendations and best clinical practices regarding management of the parturient during the transition periods of the peripartum, intrapartum, and postpartum period. Novel approaches and perspectives from case reports and narrative experience will also be discussed. There are many opportunities in this field for further studies, research, and evidence-based guidelines that promote an established standard of care.

PubMed Disclaimer

References

    1. Ko JY, D’Angelo DV, Haight SC, et al. Vital signs: prescription opioid pain reliever use during pregnancy - 34 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep 2020; 69:897–903.
    1. Haight SC, Ko JY, Tong VT, et al. Opioid use disorder documented at delivery hospitalization - United States, 1999–2014. MMWR Morb Mortal Wkly Rep 2018; 67:845–849.
    1. Mitra A, Brandt J, Rosen T, et al. Opioid use disorder: a poorly understood cause of maternal mortality in the United States [26E]. Obstet Gynecol 2020; 135:56S.
    1. Wilson N, Kariisa M, Seth P, et al. Drug and opioid-involved overdose deaths - United States, 2017–2018. MMWR Morb Mortal Wkly Rep 2020; 69:290–297.
    1. Committee on Obstetric Practice, American Society of Addiction Medicine. Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol 2017; 130:e81–e94.